When was Big Picture Bio founded?

Big Picture Bio was founded in 2026 and raised its 1st funding round within a year of its incorporation.

Where is Big Picture Bio located?

Big Picture Bio is headquartered in London, United Kingdom.

Is Big Picture Bio a funded company?

Big Picture Bio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Sep 24, 2026.

When was the latest funding round of Big Picture Bio?

Big Picture Bio's latest funding was a $***** Seed round on Sep 24, 2026, with participation from 3 investors.

Where does Big Picture Bio rank among its competitors?

Big Picture Bio ranks 18th amongst 124 active competitors, of which 7 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Big Picture Bio, which secured $1.99M in Sep, 2026.

Who are the top competitors of Big Picture Bio?

Big Picture Bio's top competitors include ConcR, HQS Quantum Simulations and Aganitha. Among them, Big Picture Bio secured the most recent funding round in September, 2026.

Big Picture Bio - 2026 Company Profile, Funding & Competitors

Company Details

Developer of predictive models for identifying synergistic drug combination therapies. The platform analyzes biological interactions to determine drug efficacy and identify pairings that prevent the regrowth of resistant cells. It processes complex data to simulate how different treatments interact within various disease environments. The technology assists in selecting targets for pharmaceutical research, evaluating existing drug portfolios, and determining effective pairings for therapeutic development. By modeling these interactions, the system seeks to identify combinations that achieve long-term disease control rather than temporary responses.

Website: bigpicturebio.com
Social
Email ID: *****@bigpicturebio.com

Key Metrics

Founded Year

2026

Location

London, United Kingdom

Stage

Seed

Total Funding

$1.99M in 1 round

Latest Funding Round

Seed, Sep 24, 2026, $*****

Investors

Kadmos Capital & 2 more

Ranked

18^th among 124 active competitors

Similar Companies

ConcR & 132 more

View Big Picture Bio's full profile

Big Picture Bio has raised a total funding of $1.99M over 1 round. Its latest funding round was a Seed round on Sep 24, 2026 for $*****. 3 investors participated in its latest round. Big Picture Bio has 2 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Big Picture Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 24, 2026	5178841	Seed	2909589	1523938	8878587	5170207

Access funding benchmarks and valuations. Sign up today!

View details of Big Picture Bio's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Big Picture Bio include ConcR, HQS Quantum Simulations and Aganitha. Here is the list of Top 10 competitors of Big Picture Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ConcR 2018, London (United Kingdom), Seed	Provider of a platform predicting therapeutic response and outcome for cancer	$3.07M	Avonmore Developments, Cambridge Angels & 8 others	44/100
2nd	HQS Quantum Simulations 2017, Karlsruhe (Germany), Series A	Developer of quantum simulation software for spectroscopy and related techniques	$16.2M	b2venture, UVC Partners & 10 others	43/100
3rd	Aganitha 2017, Hyderabad (India), Funding Raised	Provider of AI-powered drug discovery and development solutions	-	C-CAMP, Technextchallenge & 1 others	42/100
4th	Cellumen 2004, Pittsburgh (United States), Acquired	Biomarkers, antibodies, assay kits, and reagents for life science research	$12.2M	Novitas Capital, Innovation Works & 2 others	35/100
5th	PointCross 2000, Foster City (United States), Seed	Life science software solutions for clinical data automation and regulatory submissions	$120K	-	33/100
6th	Slickbit India, Unfunded	Developer of artificial intelligence software for the life sciences industry	-	-	30/100
7th	Kinentia Biosciences 2007, Albany (United States), Unfunded	Drug discovery and development services, chemoinformatics, and chemical catalog provider	-	-	28/100
8th	Topos Bio San Francisco (United States), Unfunded	Developer of computational platforms for analyzing intrinsically disordered protein structures	-	-	25/100
9th	Conifer Point 2015, Doylestown (United States), Acquired	Developer of new drugs using custom fragment-based drug design software	-	HHS	25/100
10th	Emergentec 2002, Vienna (Austria), Funding Raised	Computational solutions and consulting for better decision making in biomarker, target and drug development.	-	Europa	25/100
18th	Big Picture Bio 2026, London (United Kingdom), Seed	Developer of predictive models for identifying synergistic drug combination therapies	$1.99M	Kadmos Capital, Exceptional Ventures & 1 others	24/100